The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Suboptimal statin adherence and discontinuation in primary and secondary prevention populations: Should we target patients with the most to gain?
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
SCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,645
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
Hepherd, J. A. S., Obbe, S. T. M. C., Ord, I. A. F., Sles, C. H. G. I., Orimer, A. R. O. L., Acfarlane, P. E. W. M., Illop, J. A. H. M. C. K., Ackard, C. H. J. P., & Roup, S. T. G. (1995) · Cited by 3,453
Cited by
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Factors affecting therapeutic compliance: A review from the patient’s perspective
Li, S.-C. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s1458 · Cited by 1,265
Levesque, L. E., Hanley, J. A., Kezouh, A., & Suissa, S. (2010) · BMJ · doi:10.1136/bmj.b5087 · Cited by 1,182
Goldman, D. P., Joyce, G. F., & Zheng, Y. (2007) · JAMA · doi:10.1001/jama.298.1.61 · Cited by 874
Discontinuation of Statins in Routine Care Settings: A Cohort Study
Zhang, H., Plutzky, J., Skentzos, S., Morrison, F., Mar, P., Shubina, M., & Turchin, A. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-7-201304020-00004 · Cited by 548
Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease
Newby, L. K., Allen LaPointe, N. M., Chen, A. Y., Kramer, J. M., Hammill, B. G., DeLong, E. R., Muhlbaier, L. H., & Califf, R. M. (2006) · Circulation · doi:10.1161/circulationaha.105.505636 · Cited by 505
Cohen, J. D., Brinton, E. A., Ito, M. K., & Jacobson, T. A. (2012) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2012.03.003 · Cited by 486
“Racial/ethnic minorities are reported less likely to be adherent to statins than Caucasian patients.(19,29,42,46) In NEPTUNE II, black patients had a significantly lower frequency of LDLC treatment success (54%) compared with non-Hispanic white individuals (69%; P , .”
BackgroundPrevalence of statin intolerance: a meta-analysis
Bytyçi, I., Penson, P. E., Mikhailidis, D. P., Wong, N. D., Hernandez, A. V., Sahebkar, A., Thompson, P. D., Mazidi, M., Rysz, J., Pella, D., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac015 · Cited by 481
Determinants of Adherence to Diabetes Medications: Findings From a Large Pharmacy Claims Database
Kirkman, M. S., Rowan-Martin, M. T., Levin, R., Fonseca, V. A., Schmittdiel, J. A., Herman, W. H., & Aubert, R. E. (2015) · Diabetes Care · doi:10.2337/dc14-2098 · Cited by 388
“Out-of-pocket costs are an important determinant of adherence to statins (26) and a self-reported cause of underuse of medications in one in seven insured patients with diabetes (27).”
BackgroundLim, S. S., Gaziano, T. A., Gakidou, E., Reddy, K. S., Farzadfar, F., Lozano, R., & Rodgers, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61699-7 · Cited by 372
Shrank, W. H., Hoang, T., Ettner, S. L., Glassman, P. A., Nair, K., DeLapp, D., Dirstine, J., Avorn, J., & Asch, S. M. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.3.332 · Cited by 343
Predictors of Nonadherence to Statins: A Systematic Review and Meta-Analysis
Mann, D. M., Woodward, M., Muntner, P., Falzon, L., & Kronish, I. (2010) · Annals of Pharmacotherapy · doi:10.1345/aph.1p150 · Cited by 329
Owusu, C., Buist, D. S. M., Field, T. S., Lash, T. L., Thwin, S. S., Geiger, A. M., Quinn, V. P., Frost, F., Prout, M., Yood, M. U., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.1022 · Cited by 304
Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review
De Vera, M. A., Bhole, V., Burns, L. C., & Lacaille, D. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12339 · Cited by 289
Bradley, C. K., Wang, T. Y., Li, S., Robinson, J. G., Roger, V. L., Goldberg, A. C., Virani, S. S., Louie, M. J., Lee, L. V., Peterson, E. D., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011765 · Cited by 286
Gender and racial disparities in adherence to statin therapy: A meta-analysis
Lewey, J., Shrank, W. H., Bowry, A. D. K., Kilabuk, E., Brennan, T. A., & Choudhry, N. K. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.02.011 · Cited by 267
“Among the 53 included studies, 51 evaluated adherence based on gender(8,9,17,19-66) and 11 based on race.(8,20,21,33,41-43,47,65,67,68) The maximum duration of follow-up ranged from 3 to 156 months (average 39 months).”
BackgroundAdherence to Statins, Subsequent Healthcare Costs, and Cardiovascular Hospitalizations
Pittman, D. G., Chen, W., Bowlin, S. J., & Foody, J. M. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.01.052 · Cited by 123
Alsabbagh, M. H. D. W., Lemstra, M., Eurich, D., Lix, L. M., Wilson, T. W., Watson, E., & Blackburn, D. F. (2014) · Value in Health · doi:10.1016/j.jval.2013.11.011 · Cited by 82
“[78] Ellis JJ, Erickson SR, Stevenson JG, et al.”
BackgroundResultMedication adherence among patients with chronic diseases: a survey-based study in pharmacies
Jüngst, C., Gräber, S., Simons, S., Wedemeyer, H., & Lammert, F. (2019) · QJM: An International Journal of Medicine · doi:10.1093/qjmed/hcz058 · Cited by 69
Happe, L. E., Clark, D., Holliday, E., & Young, T. (2014) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2014.20.7.677 · Cited by 69
Theofilou, P., & Panagiotaki, H. (2012) · Oncology Reviews · doi:10.4081/oncol.2012.e5 · Cited by 67
De Vera, M. A., Choi, H., Abrahamowicz, M., Kopec, J., Goycochea-Robles, M. V., & Lacaille, D. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.142455 · Cited by 64
Measurement, determinants, barriers, and interventions for exercise adherence: a scoping review
Mahmood, A., Nayak, P., Deshmukh, A., English, C., N, M., Solomon M, J., & B, U. (2023) · Journal of Bodywork and Movement Therapies · doi:10.1016/j.jbmt.2022.09.014 · Cited by 60
Medication Nonadherence After Lung Transplantation in Adult Recipients
Castleberry, A. W., Bishawi, M., Worni, M., Erhunmwunsee, L., Speicher, P. J., Osho, A. A., Snyder, L. D., & Hartwig, M. G. (2017) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2016.06.067 · Cited by 39
“Given that the recipients’ abilities to address these barriers are limited, resources allocated to improving adherence should focus on high-risk populations who are the most likely to benefit from their use [24].”
BackgroundMcNaughton, R. J., & Shucksmith, J. (2015) · Journal of Public Health · doi:10.1093/pubmed/fdu066 · Cited by 30
Reston, J. T., Buelt, A., Donahue, M. P., Neubauer, B., Vagichev, E., & McShea, K. (2020) · Annals of Internal Medicine · doi:10.7326/m20-4680 · Cited by 28
Skilving, I., Eriksson, M., Rane, A., & Ovesjö, M.-L. (2016) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-016-2105-2 · Cited by 28
Kypridemos, C., Bandosz, P., Hickey, G. L., Guzman-Castillo, M., Allen, K., Buchan, I., Capewell, S., & O’Flaherty, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0123112 · Cited by 15
Gadowski, A. M., Nanayakkara, N., Heritier, S., Magliano, D. J., Shaw, J. E., Curtis, A. J., Zoungas, S., & Owen, A. J. (2019) · Nutrients · doi:10.3390/nu11081858 · Cited by 8
Metadata
- Authors
- Ellis, J. J., Erickson, S. R., Stevenson, J. G., Bernstein, S. J., Stiles, R. A., & Fendrick, A. M.
- Venue
- Journal of General Internal Medicine
- Published
- 2004-06
- Volume
- 19
- Issue
- 6
- Pages
- 638-645
- ISSN
- 0884-8734 (ISSN-L)
- 1525-1497
- OpenAlex
- W1533985811
- Cited by
- 323
- References
- 33
- FWCI
- 13.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.